Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Material Capacity Increase

1 Dec 2020 07:00

RNS Number : 0057H
Helios Underwriting Plc
01 December 2020
 

 

Helios Underwriting plc

("Helios" or the "Company")

 

Material Capacity Increase

 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's is pleased to announce an update on the Company's capacity portfolio and its value for 2021 year of account.

 

 Nigel Hanbury, Chief Executive of Helios, commented:

"I am delighted that the capacity portfolio will underwrite £110m for the 2021 underwriting year, a 60% increase on the size of the portfolio in January 2019 and an increase in the capacity retained by Helios' shareholders of 183% to £59m."

 

Capacity Update

Helios announces that the underwriting capacity for Helios for the 2021 year of account will be £110m a 60% increase in the capacity underwritten at the start of 2020.

 

Helios - 2021 Year of Account Capacity

£m

Retained

Reinsured

Total

Capacity as at 1st January 2021

58.7

51.5

110.3

Capacity as at 1st January 2020

20.7

48.4

69.1

% Increase

183%

7%

60%

 

Helios will only slightly increase the level of capacity reinsured in 2021 thereby increasing its retained capacity to approximately £59m, an increase of 183% over the retained capacity for 2020 underwriting year. Given the much improved underwriting pricing going into 2021, the prospects for underwriting profitability have substantially improved and this increase in the retained capacity should benefit the Company's shareholders. The reinsurance of the "on-risk" open year of account both mitigates the downside risk and provides the necessary underwriting capital for that proportion of the portfolio.

 

Following the recent announcement of the acquisition of four LLVs, the split of capacity between retained and that reinsured for the current open years of account is as follows:

 

2018 to 2020 Years of Account

 

2018

2019

2020

 

£m

£m

£m

Capacity - Position as at 1st Jan 2020

64.5

61.1

69.1

Retained

26.3

22.1

20.7

Reinsured

38.2

39.0

48.4

Capacity acquired during 2020

 

 

 

Retained

9.8

9.2

10.1

Reinsured

0.0

0.0

0.8

Capacity - Position as at 1st Dec 2020

 

 

 

Retained

36.1

31.3

30.9

Reinsured

38.2

39.0

49.1

 

74.3

70.3

80.0

 

The increased retained capacity on the 2018 to 2020 years of account, substantially "off-risk" underwriting years, is expected to contribute to the recognised future profits of the Company.

 

Capacity Value

The value of the capacity fund as at 31st December 2020 using the weighted average prices of capacity from the 2020 Lloyd's capacity auctions has increased to £30.8m (31st December 2019: £26.3m).

 

 

Capacity

Value of Capacity

 

£m

£m

2020 Capacity at 31 Dec 2019

69.11

26.35

Capacity acquired with LLV's in 2020

10.88

4.93

Capacity revaluation having included pre-emptions

10.69

0.85

Net increase in capacity after disposals at the capacity auction

19.58

-1.30

2021 Capacity at 31 Dec 2020

110.26

30.83

 

 

 

 

2019

2020

Capacity with value

57.84

82.76

Free capacity

11.27

27.49

 

69.11

110.26

 

A summary of the movements in capacity and its value are:

 

Helios acquired five LLVs during 2020 with capacity of £10.9m, which were valued at 2019 capacity prices at £4.9m.

 

The syndicates supported by Helios offered free capacity of £10.7m by way of pre-emptions to support the improved underwriting market. The overall change in average prices from 2019 together with the value of the pre-emptions taken up have increased the value of the portfolio by £0.8m.

 

Helios continued to manage the capacity portfolio discarding unwanted syndicates and taking positions on new syndicates, in particular syndicate 4242 and syndicate 2010, taking additional capacity of £12.8m in total on these two syndicates. In addition, £2.4m of capacity was sold at the auctions to raise additional net cash of £1.3m.

 

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive 07787 530404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer 07754 965 917

Shore Capital

Robert Finlay/David Coaten 020 7408 4090

 

Buchanan

Helen Tarbet/ Henry Wilson /George Beale 020 7466 5000

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £110m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBLFXBFLXFBE
Date   Source Headline
29th Nov 20167:00 amRNSQuarterly Syndicate Forecasts
1st Nov 20162:56 pmRNSHolding(s) in Company
27th Oct 20161:22 pmRNSResults of GM and of Open Offer and TVR
10th Oct 201610:50 amRNSPosting of circular
6th Oct 20163:36 pmRNSHolding(s) in Company
30th Sep 20162:55 pmRNSResult of Placing and Open Offer Timetable
30th Sep 20167:01 amRNSProposed Placing and Open Offer
30th Sep 20167:00 amRNSHalf-year Report
25th Aug 201610:55 amRNSSyndicate Forecasts
3rd Aug 20164:29 pmRNSTotal Voting Rights
18th Jul 20165:14 pmRNSHolding(s) in Company
6th Jul 20165:30 pmRNSIssue of Equity
6th Jul 20165:30 pmRNSDirector/PDMR Shareholding
29th Jun 20169:35 amRNSResult of AGM
17th Jun 20167:00 amRNSScrip Dividend Reference Price
7th Jun 20165:38 pmRNSHolding(s) in Company
7th Jun 20167:00 amRNSSyndicate Forecasts
1st Jun 20165:41 pmRNSFinal Results - Replacement
31st May 20167:00 amRNSAppointment of Nominated Adviser and Broker
31st May 20167:00 amRNSAcquisition
31st May 20167:00 amRNSFinal Results
11th Apr 20167:00 amRNSDirectorate Change
23rd Mar 20164:39 pmRNSChange of Registered Office
22nd Mar 20167:00 amRNSSyndicate Forecasts
17th Feb 20165:14 pmRNSDirector/PDMR Shareholding
22nd Jan 20167:00 amRNSAcquisition
3rd Dec 201511:34 amRNSSyndicate Forecasts
30th Sep 201510:47 amRNSTotal Voting Rights
25th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20158:19 amRNSAcquisition
24th Aug 20157:00 amRNSSyndicate Forecasts
3rd Aug 20157:00 amRNSAcquisition
15th Jul 20157:00 amRNSAcquisitions
3rd Jul 20151:32 pmRNSDirector/PDMR Shareholding
30th Jun 20157:00 amRNSIssue of Equity
25th Jun 20154:11 pmRNSResult of AGM
19th Jun 201511:47 amRNSDirector/PDMR Shareholding
12th Jun 20155:25 pmRNSCompletion of Acquisition
12th Jun 20157:00 amRNSScript Dividend Reference Price
5th Jun 20157:00 amRNSSyndicate Forecasts
2nd Jun 20159:42 amRNSPosting of Annual Report & Notice of AGM
26th May 20158:06 amRNSFinal Results
31st Mar 201512:04 pmRNSTotal Voting Rights
17th Mar 20157:00 amRNSSyndicate Forecasts
13th Mar 20154:02 pmRNSAcquisition
11th Mar 201511:35 amRNSDirector/PDMR Shareholding
20th Feb 20154:12 pmRNSCompletion of Acquisition
18th Feb 20153:45 pmRNSDirector/PDMR Shareholding
18th Feb 20157:00 amRNSDirector/PDMR Shareholding
17th Feb 20157:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.